Year: 2023
Type: article
Study design: Case Report
Abstract: Objectives: Sacral chordoma (SC) is a rare, aggressive tumor with a high recurrence rate and originates from notochordal remnants.SC is difficult to differentiate with its non-specific symptoms such as lower back pain.Surgical treatment and radiotherapy are first-line treatments.Resection with wide margins is vital for the prevention of recurrence. Materials and Methods:Nine patients diagnosed with SC between January 2014 and December 2021 were retrospectively analyzed.All adult patients with SC were included in the study.Pediatric population was excluded from the study.Pathology, radiology and surgical records of the patients' were used.Mean age was 53.2.Results: Two out of 9 patients died during follow-up and 5 patients had local recurrence.No metastasis was observed.Conclusion: Current evidence shows that surgical treatment is necessary for SC's treatment.Radiotherapy is also an important aspect of the treatment.Existing evidence should be meta-analyzed for a better understanding of SC's treatment and outcomes.
Institutions: Ankara University, Worcestershire Royal Hospital
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4387907751
